WINNERS & LOSERS: Rolls-Royce ups guide; Rentokil slumps
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday. Read More
| Price | 1,940.00p on 30-07-2026 at 17:05:07 |
|---|---|
| Change | -67.00p -3.34% |
| Buy | 1,936.50p |
| Sell | 1,935.50p |
| Last Trade: | Sell 619.00 at 1,940.00p |
| Day's Volume: | 7,052,592 |
| Last Close: | 1,940.00p |
| Open: | 1,988.50p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,935.50p - 1,994.50p |
| 52wk Range: | 1,361.00p - 2,282.00p |
| Market Capitalisation: | £77.73b |
| VWAP: | 1,951.6932p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 619 | 1,940.00p | Ordinary |
16:49:50 - 30-Jul-26 |
| Unknown* | 483,191 | 1,948.125p | SI Trade Negotiated Trade |
16:45:35 - 30-Jul-26 |
| Buy* | 1,619 | 1,940.00p | Automatic Execution |
16:39:00 - 30-Jul-26 |
| Buy* | 100 | 1,940.00p | Automatic Execution |
16:39:00 - 30-Jul-26 |
| Buy* | 1,100 | 1,940.00p | Automatic Execution |
16:39:00 - 30-Jul-26 |
| Buy* | 200 | 1,940.00p | Automatic Execution |
16:36:45 - 30-Jul-26 |
| Buy* | 750 | 1,940.00p | Automatic Execution |
16:36:45 - 30-Jul-26 |
| Buy* | 175 | 1,940.00p | Automatic Execution |
16:36:45 - 30-Jul-26 |
| Buy* | 175 | 1,940.00p | Automatic Execution |
16:36:45 - 30-Jul-26 |
| Buy* | 199 | 1,940.00p | Automatic Execution |
16:36:28 - 30-Jul-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 28th Jul 2026 12:05 pm | RNS | New GSK flagship R&D centre in Cambridge |
| 28th Jul 2026 12:00 pm | RNS | 2nd Quarter Results |
| 28th Jul 2026 11:06 am | RNS | Hansoh positive 2nd Phase III results for Riz-Rez |
| 24th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 24th Jul 2026 3:00 pm | RNS | Admission to Trading |
| 22nd Jul 2026 5:22 pm | RNS | Jideytro approved in US for certain lung cancers |
| 20th Jul 2026 7:00 am | RNS | Bexsero 1-dose booster EMA file acceptance |
| 17th Jul 2026 12:00 pm | RNS | Audit tender conclusion |
| 17th Jul 2026 9:30 am | RNS | Camlipixant phase III results update |
| 16th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |